Revolutionizing Pharma: The Power of AI and Chatbots in Clinical Trials and Beyond

Psychiatric Times October 15, 2024
Steven E. Hyler, MD

Learn more about how AI can transform mental health care.

CHATBOT CORNER

The pharmaceutical industry is in the midst of a transformative revolution driven by advancements in large language models (LLMs), generative artificial intelligence (AI), and chatbots. These technologies offer unprecedented opportunities to enhance clinical trials, streamline the dissemination of pharmaceutical information, and accelerate drug discovery.¹ In this manuscript, we explore how AI is being utilized to improve efficiency, ensure better patient outcomes, and revolutionize communication strategies in the pharmaceutical landscape. Furthermore, we delve into the current challenges and opportunities of AI integration and highlight significant AI investments in the industry.

Enhancing Clinical Trials with Generative AI

Clinical trials are the backbone of pharmaceutical research, providing the evidence needed to...

Today's Sponsors

Today's Sponsor